Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.
Recruiting now
Conditions studied: Fertility Disorders
In brief
This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.
Key facts
- Study ID
- NCT06928337
- Run by
- Fairtility
- People needed
- 350
- Starts
- 2025-05-01
- Expected to finish
- 2026-05-01
- Last updated by the study team
- 2025-08-07
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Women at least 18 years of age.
- Embryos or eggs cultured in a time-lapse incubator connected to CHLOE Embryo Viewer.
You may not qualify if…
- Women with autologous eggs
Where it is running
- The World Egg and Sperm Bank — Scottsdale, Arizona, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.